Transforming growth factor-beta 1 enhances polymorphonuclear leucocyte accumulation in dermal inflammation and transendothelial migration by a priming action
- PMID: 8473013
- PMCID: PMC1421793
Transforming growth factor-beta 1 enhances polymorphonuclear leucocyte accumulation in dermal inflammation and transendothelial migration by a priming action
Abstract
Acute inflammatory reactions are usually characterized by polymorphonuclear leucocyte (PMNL) migration into inflamed tissues. Transforming growth factors-beta 1 (TGF-beta 1) may be involved in inflammatory reactions but its actions are controversial and require further in vivo studies. We employed a rabbit dermal inflammation model to investigate the effect of TGF-beta 1 on PMNL migration induced by cytokines and chemotactic factors, using 51Cr-labelled leucocytes to quantify PMNL accumulation in dermal lesions. Injection of TGF-beta 1, over a wide dose range, alone did not elicit PMNL accumulation (0.14 x 10(6) PMNL/site). This contrasted with responses to interleukin-1 alpha (IL-1 alpha) (11.8 x 10(6) PMNL/site), tumour necrosis factor-alpha (TNF-alpha) (4.5), lipopolysaccharide (LPS) (14.9), FNLP (10.1), or IL-8 (6.6). However, when sites were pretreated for 3 hr with TGF-beta 1 (1-10 ng) and subsequently re-injected with the inflammatory stimuli, TGF-beta 1 primed the tissue for an enhanced recruitment of PMNL in response to the endothelium-activating inflammatory agents, IL-1 alpha, TNF-alpha and LPS, but not to IL-8 or FNLP, which are directly PMNL chemotactic. For example, with IL-1 alpha, PMNL accumulation was 205% greater than the additive sum of each response alone (P < 0.05). This was confirmed histologically. TGF-beta 1 pretreatment enhanced PMNL accumulation over a wide dose range of IL-1 alpha and LPS. TGF-beta 1 did not alter the kinetics of IL-1 alpha or LPS-induced PMNL accumulation, but increased the peak rate of accumulation in lesions. Using an in vitro PMNL transendothelial migration system, TGF-beta 1 (10 ng/ml) was found to prime the endothelium for responsiveness to a submaximal dose of IL-1 alpha (0.005 ng/ml) or a threshold dose of LPS (0.01 ng/ml), resulting in enhanced PMNL transendothelial migration. Thus, TGF-beta 1 may have a role in priming the microvasculature for enhanced PMNL emigration, especially in response to endothelium-activating agents.
Similar articles
-
Thrombin enhancement of interleukin-1 and tumor necrosis factor-alpha induced polymorphonuclear leukocyte migration.Lab Invest. 1992 Nov;67(5):617-27. Lab Invest. 1992. PMID: 1434539
-
Endotoxin activation of endothelium for polymorphonuclear leucocyte transendothelial migration and modulation by interferon-gamma.Immunology. 1993 Aug;79(4):600-7. Immunology. 1993. PMID: 8104889 Free PMC article.
-
Polymorphonuclear leucocyte migration through human dermal fibroblast monolayers is dependent on both beta 2-integrin (CD11/CD18) and beta 1-integrin (CD29) mechanisms.Immunology. 1995 Jul;85(3):485-94. Immunology. 1995. PMID: 7558139 Free PMC article.
-
[Modulation of the oxidative burst of human neutrophils by pro- and anti-inflammatory cytokines].Pathol Biol (Paris). 1996 Jan;44(1):36-41. Pathol Biol (Paris). 1996. PMID: 8734298 Review. French.
-
The role of cytokines in osteoarthritis pathophysiology.Biorheology. 2002;39(1-2):237-46. Biorheology. 2002. PMID: 12082286 Review.
Cited by
-
Characterization of transendothelial migratory lymphokine-activated killer cells.Jpn J Cancer Res. 1996 Apr;87(4):395-400. doi: 10.1111/j.1349-7006.1996.tb00235.x. Jpn J Cancer Res. 1996. PMID: 8641971 Free PMC article.
-
Modified skin-window technique in cynomolgus macaques (Macaca fasicularis) for assessing neutrophil extravasation.J Am Assoc Lab Anim Sci. 2010 Jul;49(4):475-9. J Am Assoc Lab Anim Sci. 2010. PMID: 20819396 Free PMC article.
-
Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation.EMBO J. 2005 Oct 5;24(19):3400-10. doi: 10.1038/sj.emboj.7600809. Epub 2005 Sep 8. EMBO J. 2005. PMID: 16148944 Free PMC article.
-
In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-beta 1: age-related differences.Ann Rheum Dis. 1994 Sep;53(9):593-600. doi: 10.1136/ard.53.9.593. Ann Rheum Dis. 1994. PMID: 7979598 Free PMC article.
-
Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.Immunology. 1995 Jul;85(3):400-7. Immunology. 1995. PMID: 7558128 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources